Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 5:04 AM
Ignite Modification Date: 2025-12-26 @ 4:06 AM
NCT ID: NCT01143818
Description: Treatment-emergent adverse events that were not serious occurred in 64 patients. None of the adverse events occured at a frequency threshold of \>=5%. Therefore, no adverse events were reported.
Frequency Threshold: 5
Time Frame: All reported adverse events are treatment-emergent and are defined as events that started or worsened at or after the first administration of AndroGel and ended before or at treatment completion. Only suspected adverse drug reactions were collected.
Study: NCT01143818
Study Brief: ESPRIT Study in Hypogonadal Men
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
AndroGel (Testosterone Gel) 1% Topical testosterone gel 1% (1 sachet of 5 g contains 50 mg of testosterone), 1 daily dose. All participants who received at least 1 dose of study drug are included in the safety analysis set. None None 3 1049 0 1049 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Angina pectoris None Cardiac disorders MedDRA (11.0) View
Atrial fibrillation None Cardiac disorders MedDRA (11.0) View
Hypertension None Vascular disorders MedDRA (11.0) View
Nausea None Gastrointestinal disorders MedDRA (11.0) View
Other Events(If Any):